Oct 03, 2025 • Zacks Commentary
BULLISH
DaVita HealthCare ( DVA ) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Oct 02, 2025 • Zacks Commentary
BULLISH
Why DaVita HealthCare ( DVA ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sep 30, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
DaVita HealthCare ( DVA ) Rises Higher Than Market: Key Facts
In the latest trading session, DaVita HealthCare (DVA) closed at $132.87, marking a +1.75% move from the previous day.
Sep 25, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant
Quest Diagnostics, DaVita, Addus HomeCare, and The Pennant Group are positioned to benefit from telehealth, AI adoption, and rising demand in the $747B home healthcare market.
Sep 24, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, ADUS and PNTG are well-poised to gain.
Sep 24, 2025 • Business Insider
SOMEWHAT-BULLISH
VSee Health Secures Nasdaq Approval for Continued Listing
. ( Nasdaq: VSEE ) ( the "Company" ) , a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ( "Nasdaq" ) in a letter dated September 15, 2025, that the ...